Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology
Infection and Drug Resistance · 2026-09 · Volume 19 · 1-14
DOI: 10.2147/idr.s622829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-09. Verfasst von Qiuyan Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzho…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Mycoplasma pneumoniae pneumonia (MPP) is a common cause of community-acquired pneumonia in children, yet its metabolic alterations and pathogenic mechanisms remain incompletely understood. This study aimed to characterize the plasma metabolomic profile of children with MPP and explore associated metabolic pathways.
Methods
This retrospective case-control study involved 42 children including 14 MPP patients, 14 non-MPP (MPN) patients, and 14 healthy controls (HC). Clinical and laboratory data were compared across groups. Plasma metabolomic profiling was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Multivariate statistical analyses, including principal component analysis (PCA), partial least squares-discriminant analysis (PLS-DA), and orthogonal partial least squares-discriminant analysis (OPLS-DA), were employed to identify metabolic differences among groups. Pathway enrichment analysis used the KEGG and Reactome databases.
Results
Clinically, the MPP group exhibited significantly higher C-reactive protein (CRP) levels and neutrophil percentages, and lower lymphocyte percentages (all P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, People's Republic of China.
- Department of Pharmacy, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, People's Republic of China.
- Institute of Clinical Medicine Research, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, People's Republic of China.
ORCID-Profile: Qiuyan Xu
Zitieren
APA
Xu, Q., Shen, L., Hong, L., Li, X., Lu, M., & Ran, S. (2026). Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology. Infection and Drug Resistance, Volume 19, 1-14. https://doi.org/10.2147/idr.s622829
Vancouver
Xu Q, Shen L, Hong L, Li X, Lu M, Ran S. Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology. Infection and Drug Resistance. 2026;Volume 19:1-14. doi:10.2147/idr.s622829
BibTeX
@article{Xu2026,
author = {Xu, Qiuyan and Shen, Li and Hong, Lei and Li, Xiang and Lu, Min and Ran, Shuangqin},
title = {Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/idr.s622829}
}
EUVIMED